Telemark Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-240,450	Closed	-$17.1M	–	41
2019 Q2	$17.1M	Buy	+240,450	New	+$17.1M	1.96%	21